City

Amsterdam (1)

Bern (1)

Groningen (1)

Richmond (1)

Rotterdam (1)

Zuerich (1)

Condition

Leukemia (2)

Myeloid (2)

Acute (1)

Monocytic (1)

Relapsed (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Molecular Partners AG (1)

Virginia Commonwealth University (1)

Collaborator

Massey Cancer Center (1)

Intervention

bsma (1)

mp0533 (multispecific darpin cd3 engager targeting cd33, cd123 and cd70) (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

myeloid

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting

Leukemia
+3 more

MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)

Amsterdam, Netherlands
+4 more

Jan 4, 2023

Leukemia, Myeloid, Monocytic Trial in Richmond (BSMA)

Completed

Leukemia
+2 more

BSMA

Richmond, Virginia

Virginia Commonwealth University/Massey Cancer Center

Jan 5, 2017